77 Results for "

SPR

" in MedChemExpress (MCE) Product Catalog:
Products (77)

77 Results for "SPR" in MCE Product Catalog:

55
55 Publications Verification
Cat. No.: HY-P9905
CAS No.: 205923-56-4
Synonyms: C225; IMC-C225

Research Areas:  

Cancer

Cetuximab (C225) is a human IgG1 monoclonal antibody that inhibits epidermal growth factor receptor (EGFR), with a Kd of 0.201 nM for EGFR by SPR. Cetuximab has potent antitumor activity .
loading...
    loading...
22
22 Cited Publications
Cat. No.: HY-101533
CAS No.: 2143061-81-6
Purity:  99.79%
Target:  

Bcl-2 Family

Research Areas:  

Cancer

AZD-5991 is a potent and selective Mcl-1 inhibitor with an IC50 of 0.7 nM in FRET assay and a Kd of 0.17 nM in surface plasmon resonance (SPR) assay .
loading...
    loading...
4
4 Cited Publications
Cat. No.: HY-13963
CAS No.: 587841-73-4
Purity:  98.49%
ZCL278 is a selective Cdc42 inhibitor with Kds of 6.4 μM in fluorescence titration and 11.4 μM in surface plasmon resonance (SPR) measurement. ZCL278 is able to disrupt the Cdc42-ITSN interaction as well as GTP/GDP binding. ZCL278 has inhibitory effects on various enveloped viruses, but is ineffective against non-enveloped viruses. ZCL278 can be used for the studies of arsenic neurotoxicity and HER2-positive gastric cancer (GC) .
loading...
    loading...
4
4 Cited Publications
Cat. No.: HY-12930
CAS No.: 1384984-18-2
Purity:  99.50%
Synonyms: VXc-486
Target:  

Topoisomerase Bacterial

Research Areas:  

Infection

SPR719 (VXc-486) is an orally active gyrase B inhibitor, with bactericidal activity. SPR719 potently inhibits multiple agent-sensitive isolates and drug-resistant isolates of Mycobacterium tuberculosis, with MICs of 0.03 to 0.30 μg/ml and 0.08 to 5.48 μg/ml, respectively. SPR719 is promising for research of lung disease caused by non-tuberculous mycobacteria (NTM) .
loading...
    loading...
3
3 Cited Publications
Cat. No.: HY-P1649
CAS No.: 1179330-52-9
Synonyms: NAB741
Target:  

Bacterial Antibiotic

Research Areas:  

Infection

SPR741 (NAB741) is a cationic peptide derived from polymyxin B and is a potentiator molecule. SPR741 increases the permeability of the outer membrane of Gram-negative bacteria and is used to treat severe Gram-negative bacteria infections. SPR741 inhibits multidrug-resistant Gram-negative bacteria. The spectrum of activity of the antibiotic can be widened when used in combination with SPR741 .
loading...
    loading...
3
3 Cited Publications
Cat. No.: HY-P1649B
Synonyms: NAB741 acetate
Target:  

Bacterial Antibiotic

Research Areas:  

Infection

SPR741 acetate (NAB741 acetate) is a cationic peptide derived from polymyxin B and is a potentiator molecule. SPR741 acetate increases the permeability of the outer membrane of Gram-negative bacteria and is used to treat severe Gram-negative bacteria infections. SPR741 acetate inhibits multidrug-resistant Gram-negative bacteria. The spectrum of activity of the antibiotic can be widened when used in combination with SPR741 acetate .
loading...
    loading...
3
3 Cited Publications
Cat. No.: HY-114388
CAS No.: 2093421-02-2
Purity:  99.48%
Research Areas:  

Inflammation/Immunology

QM385 is a potent sepiapterin reductase (SPR) inhibitor with an IC50 of 1.49 nM, which blocks T-cell proliferation and autoimmunity at nanomolar potency and with good oral bioavailability .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-128780B
CAS No.: 2408422-41-1
Purity:  99.74%
Target:  

Bacterial Antibiotic

Research Areas:  

Infection

SPR206 acetate is a polymyxin analog with antibiotic activity against Gram-negative pathogens, including multidrug-resistant (MDR) variants. SPR206 acetate has an anti-bacterial infection effect by interacting with the bacterium’s outer membrane. The MIC values of SPR206 acetate against Pseudomonas aeruginosa Pa14 and Acinetobacter baumannii NCTC13301 are both 0.125 mg/L .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-122611A
CAS No.: 1353749-74-2
Purity:  99.97%
Research Areas:  

Cancer

CSRM617 hydrochloride is a selective small-molecule inhibitor of the transcription factor ONECUT2 (OC2, a master regulator of androgen receptor) with a Kd of 7.43 uM in SPR assays, binding to OC2-HOX domain directly. CSRM617 hydrochloride induces apoptosis by appearance of cleaved Caspase-3 and PARP. CSRM617 hydrochloride is well tolerated in the prostate cancer mouse model
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-115510
CAS No.: 1292285-54-1
Purity:  99.84%
Synonyms: SPRi3
Target:  

Carbonyl Reductase

Research Areas:  

Inflammation/Immunology

SPR inhibitor 3 (SPRi3) is a potent sepiapterin reductase (SPR) inhibitor. SPR inhibitor 3 (SPRi3) displays high binding affinity to human SPR in a cell-free assay (IC50=74 nM) and efficiently reduces biopterin levels in a cell-based assay (IC50=5.2 μM). SPR inhibitor 3 (SPRi3) reduces neuropathic and inflammatory pain through a reduction of BH4 levels .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-101964
CAS No.: 1051387-90-6
Purity:  98.01%
Target:  

SHP2 Phosphatase

Research Areas:  

Cancer

SPI-112 is a potent, selective and competitive SHP2 (PTPN11) inhibitor with IC50s of 1 μM, 18.3 μM and 14.5 μM for SHP2, protein tyrosine phosphatase (PTP) and PTP1B, respectively .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-159652
CAS No.: 2920695-77-6
Target:  

Ras

Research Areas:  

Cancer

KRAS inhibitor-31 (compound 33) is a KRAS inhibitor, with KD (SPR) values of 0.019 nM, 0.019 nM and 0.096 nM for KRas G12D, KRas G12C and KRas G12V, respectively .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-135655
CAS No.: 1384984-20-6
Purity:  99.53%
Synonyms: SPR720 disodium; pVXc-486 disodium
Target:  

Bacterial

Research Areas:  

Infection

Fobrepodacin (SPR720) disodium is an orally active and potent phosphate proagent of SPR719 (VXc-486; HY-12930). Fobrepodacin disodium has potent bactericidal activities in vivo .
loading...
    loading...
Cat. No.: HY-P9S0008

Research Areas:  

Cancer

Cetuximab (PBS) is a human IgG1 monoclonal antibody that can inhibit EGFR. The SPR method measured the Kd value of Cetuximab for EGFR to be 0.201 nM; Cetuximab has a highly effective anti-tumor effect .
loading...
    loading...
Cat. No.: HY-177512
CAS No.: 3098173-17-9
Target:  

FLAP

Research Areas:  

Cancer

MSC778 is an effective and orally active flap endonuclease 1 (FEN1) inhibitor with an IC50 of 3 nM and a KD of 2.9 nM. MSC778 exhibits 145-fold, 516-fold, and 65-fold selectivity over EXO1, GEN1, and XPG, respectively. MSC778 selectively kills BRCA2-deficient cells and potentiates the activity of Niraparib (HY-10619) to induce tumor stasis in a BRCA2 KO DLD-1 mouse xenograft. MSC778 can be used in the research of colorectal cancer .
loading...
    loading...
Cat. No.: HY-135691
CAS No.: 2313528-04-8
Purity:  ≥97.0%
Target:  

c-Myc Apoptosis

Research Areas:  

Cancer

hnRNPK-IN-1 is a heterogeneous nuclear ribonucleoprotein K (hnRNPK) binding ligand with Kd values of 4.6 μM and 2.6 μM measured with SPR and MST, respectively. hnRNPK-IN-1 inhibits c-myc transcription by disrupting the binding of hnRNPK and c-myc promoter. hnRNPK-IN-1 induces Hela cells apoptosis and has strongly anti-tumor activities .
loading...
    loading...
Cat. No.: HY-175207
CAS No.: 3109469-27-1
Target:  

Glycosidase

Research Areas:  

Cancer

CHI3L1-IN-3 is a CHI3L1 inhibitor. CHI3L1-IN-3 binds to CHI3L1 with Kds of 13.76 μM and 13.5 μM in MST and SPR assays, respectively. CHI3L1-IN-3 demonstrates extended plasma half-lives and microsomal stability, along with reduced intrinsic clearance. CHI3L1-IN-3 induces dose-dependent cytotoxicity, reduces spheroid mass and inhibits migration in a 3D multicellular glioblastoma (GBM) spheroid model. CHI3L1-IN-3 can be used for the study of GBM .
loading...
    loading...
Cat. No.: HY-113603
CAS No.: 1014983-00-6
Purity:  98.25%
Synonyms: SPR001; LY2371712
Target:  

CRFR

Research Areas:  

Metabolic Disease

Tildacerfont (SPR001; LY2371712) is an orally active, blood-brain barrier-penetrant selective corticotropin-releasing factor type 1 (CRF1) receptor antagonist. Tildacerfont selectively blocks CRF1 receptors, thereby inhibiting the release of pituitary adrenocorticotropic hormone (ACTH). Tildacerfont can be used in research related to congenital adrenal hyperplasia .
loading...
    loading...
Cat. No.: HY-160477
CAS No.: 300713-88-6
Target:  

PIKfyve NF-κB IKK

Research Areas:  

Inflammation/Immunology

DC-SX029 is a potent SNX10 protein-protein interaction (PPI) inhibitor with oral activity with an estimated KD constant of ~0.935 μM by surface plasmon resonance (SPR). DC-SX029 blocks the SNX10-PIKfyve interaction, thereby decreased the TBK1/c-Rel signaling activation. DC-SX029 does not affect the protein level of SNX10. DC-SX029 has the potential for inflammatory bowel disease (IBD) research .
loading...
    loading...
Cat. No.: HY-P3143
CAS No.: 1629655-80-6
Target:  

PD-1/PD-L1

Research Areas:  

Cancer

BMSpep-57 is a potent and competitive macrocyclic peptide inhibitor of PD-1/PD-L1 interaction with an IC50 of 7.68 nM. BMSpep-57 binds to PD-L1 with Kds of 19 nM and 19.88 nM in MST and SPR assays, respectively. BMSpep-57 facilitates T cell function by in creasing IL-2 production in PBMCs .
loading...
    loading...